Health ❯ Pharmaceuticals

Drug Development

Clinical Trials Weight Loss Drugs Regulatory Affairs Clinical Research Obesity Treatments Market Competition Oncology FDA Approval Regulatory Approval Cancer Treatment

CVS Caremark Restores Zepbound and Adds Lilly’s Foundayo to Standard Formularies

CVS says the change will expand treatment options to lower costs for tens of millions of commercially insured people.

AI-Designed Miniproteins Target GPCRs in Nature Study

NervGen Prices $60 Million Public Offering of Shares and Warrants

Imperagen Raises £5 Million Seed to Scale Quantum‑AI Enzyme Platform

Immunovant Shares Surge on Strong Rheumatoid Arthritis Data for IMVT-1402

Regeneron Strikes Parabilis Deal to Develop Antibody-Helicon Drugs

FDA Opens Early Access to KRAS-Targeting Pancreatic Cancer Pill After Strong Survival Data

FDA Places Full Clinical Hold on Aardvark’s ARD-101 Prader–Willi Trials

Altimmune Targets Second-Half 2026 Launch for Global Phase 3 MASH Trial

United Therapeutics Teams With Varda to Test Space-Made Drug Formulations

Bristol Myers and Hengrui Ink Up to $15.2 Billion Drug Discovery Alliance

Novo Nordisk Lifts 2026 Outlook as Wegovy Pill Powers Big Q1 Beat

Analysts Lift Eli Lilly Targets After Blowout Quarter and Foundayo Debut

FDA Chief Makary Faces Intensifying Pressure as Vape Approvals and Staff Shake-Up Fuel Scrutiny

Mounjaro Overtakes Keytruda as World’s Best-Selling Drug in Q1 2026

HHS Push to Ease Peptide Curbs Spurs FDA Review and Investor Bets

Google Cloud Unveils Gemini Enterprise Agent Platform With Security Controls, Partner Fund and New TPUs

Gurugram Bust Exposes Counterfeit Mounjaro Operation With Suspected China Link

Corcept Investors Face Today’s Lead‑Plaintiff Deadline in Securities Case Over Relacorilant Disclosures

Lupin’s U.S. Unit Settles Humana Antitrust Claims for $30 Million